Literature DB >> 20869119

Chromatic pupillometry in patients with retinitis pigmentosa.

Randy Kardon1, Susan C Anderson, Tina G Damarjian, Elizabeth M Grace, Edwin Stone, Aki Kawasaki.   

Abstract

OBJECTIVE: To evaluate the chromatic pupillary response as a means of assessing outer and inner retinal function in patients with retinitis pigmentosa (RP).
DESIGN: Evaluation of diagnostic technology. PARTICIPANTS: Thirty-two patients with RP and visual loss and 43 normal subjects.
METHODS: Patients were tested with a chromatic pupillometer using red and blue lights (1, 10, and 100 cd/m(2)), and their pupil responses were compared with those from 43 normal subjects (reported previously). Visual field and electroretinography (ERG) results were examined and compared with the pupil responses. MAIN OUTCOME MEASURES: The percent pupil contraction of the transient response to a low-intensity (1 cd/m(2)) blue light and high-intensity (100 cd/m(2)) red light and the sustained response to a high-intensity blue light was calculated for 1 eye of each subject.
RESULTS: The pupil responses to red and blue light at all intensities were recordable in all patients except 1, whose pupil responded only to bright blue light. There was a significant difference of the pupil response between patients with RP and normal subjects in testing conditions that emphasized rod (1 cd/m(2) blue light) or cone (100 cd/m(2) red light) contribution (P<0.001). Patients with a non-recordable scotopic ERG showed significantly reduced pupil responses (P<0.001) to low-intensity blue light (1 cd/m(2)). Patients with a non-recordable or abnormal photopic ERG showed significantly reduced pupil responses (P<0.05) to high-intensity red light (100 cd/m(2)). Patients with a nonrecordable ERG had the most visual field loss and reduced pupil responses. Unexpectedly, patients with RP showed a slower re-dilation of the pupil after termination of bright blue light compared with red light, a pattern not observed in normal subjects.
CONCLUSIONS: Pupil responses to red and blue light stimuli weighted to favor cone or rod input are significantly reduced in patients with RP but are still recordable in patients having a non-recordable ERG. In addition, outer photoreceptor disease appears to unmask a post-illumination pupillary constriction to bright blue light, most likely mediated by intrinsic activation of melanopsin ganglion cells. Chromatic pupillometry provides a novel, noninvasive method for following retinal functional status, particularly in patients with severe RP and non-recordable ERG.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 20869119     DOI: 10.1016/j.ophtha.2010.06.033

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  46 in total

1.  [Current state of pupil-based diagnostics for glaucomatous optic neuropathy].

Authors:  K Skorkovská; U Schiefer; B Wilhelm; H Wilhelm
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

2.  Dark adaptation-induced changes in rod, cone and intrinsically photosensitive retinal ganglion cell (ipRGC) sensitivity differentially affect the pupil light response (PLR).

Authors:  Bin Wang; Chao Shen; Lei Zhang; Linsong Qi; Lu Yao; Jianzhang Chen; Guoqing Yang; Tao Chen; Zuoming Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-27       Impact factor: 3.117

3.  Pupillary light response after cataract surgery in healthy patients.

Authors:  Ken Hayashi; Motoaki Yoshida; Sosuke Ishiyama; Akira Hirata
Journal:  Jpn J Ophthalmol       Date:  2021-05-11       Impact factor: 2.447

4.  Retinal ganglion cell damage in an experimental rodent model of blast-mediated traumatic brain injury.

Authors:  Kabhilan Mohan; Helga Kecova; Elena Hernandez-Merino; Randy H Kardon; Matthew M Harper
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-15       Impact factor: 4.799

5.  The post illumination pupil response is reduced in seasonal affective disorder.

Authors:  Kathryn Roecklein; Patricia Wong; Natalie Ernecoff; Megan Miller; Shannon Donofry; Marissa Kamarck; W Michael Wood-Vasey; Peter Franzen
Journal:  Psychiatry Res       Date:  2013-07-01       Impact factor: 3.222

6.  Melanopsin and rod-cone photoreceptors play different roles in mediating pupillary light responses during exposure to continuous light in humans.

Authors:  Joshua J Gooley; Ivan Ho Mien; Melissa A St Hilaire; Sing-Chen Yeo; Eric Chern-Pin Chua; Eliza van Reen; Catherine J Hanley; Joseph T Hull; Charles A Czeisler; Steven W Lockley
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

7.  Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response.

Authors:  Jason C Park; Ana L Moura; Ali S Raza; David W Rhee; Randy H Kardon; Donald C Hood
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-22       Impact factor: 4.799

8.  The Melanopsin-Mediated Pupillary Light Response Is Not Changed in Patients with Newly Diagnosed Idiopathic Intracranial Hypertension.

Authors:  Shakoor Ba-Ali; Rigmor Højland Jensen; Line Sofie Larsen; Henrik Lund-Andersen; Steffen Hamann
Journal:  Neuroophthalmology       Date:  2017-08-18

Review 9.  Melanopsin, photosensitive ganglion cells, and seasonal affective disorder.

Authors:  Kathryn A Roecklein; Patricia M Wong; Megan A Miller; Shannon D Donofry; Marissa L Kamarck; George C Brainard
Journal:  Neurosci Biobehav Rev       Date:  2012-12-31       Impact factor: 8.989

10.  The pupil light reflex in Leber's hereditary optic neuropathy: evidence for preservation of melanopsin-expressing retinal ganglion cells.

Authors:  Ana Laura A Moura; Balázs V Nagy; Chiara La Morgia; Piero Barboni; André Gustavo Fernandes Oliveira; Solange R Salomão; Adriana Berezovsky; Milton Nunes de Moraes-Filho; Carlos Filipe Chicani; Rubens Belfort; Valerio Carelli; Alfredo A Sadun; Donald C Hood; Dora Fix Ventura
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-02       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.